BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29243774)

  • 1. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
    Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
    Li GL; Wu YX; Li YM; Li J
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
    Qi XD; Xu SY; Song Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
    Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of long non-coding RNA LOC730101 correlates with distant metastasis and exhibits a poor prognosis in patients with osteosarcoma.
    Li SW; Hu KZ; Chen SC; Liu SL; Wang YH
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4115-4120. PubMed ID: 30024599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
    Gao KT; Lian D
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.